Cell Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Nat Rev Endocrinol. 2023 Mar;19(3):134-150. doi: 10.1038/s41574-022-00773-5. Epub 2022 Nov 29.
Tumours exhibit notable metabolic alterations compared with their corresponding normal tissue counterparts. These metabolic alterations can support anabolic growth, enable survival in hostile environments and regulate gene expression programmes that promote malignant progression. Whether these metabolic changes are selected for during malignant transformation or can themselves be drivers of tumour initiation is unclear. However, intriguingly, many of the major bottlenecks for tumour initiation - control of cell fate, survival and proliferation - are all amenable to metabolic regulation. In this article, we review evidence demonstrating a critical role for metabolic pathways in processes that support the earliest stages of tumour development. We discuss how cell-intrinsic factors, such as the cell of origin or transforming oncogene, and cell-extrinsic factors, such as local nutrient availability, promote or restrain tumour initiation. Deeper insight into how metabolic pathways control tumour initiation will improve our ability to design metabolic interventions to limit tumour incidence.
与相应的正常组织相比,肿瘤表现出明显的代谢改变。这些代谢改变可以支持合成代谢生长,使肿瘤在恶劣的环境中存活,并调节促进恶性进展的基因表达程序。这些代谢变化是在恶性转化过程中选择的,还是本身可以成为肿瘤起始的驱动因素尚不清楚。然而,有趣的是,肿瘤起始的许多主要瓶颈——细胞命运、存活和增殖的控制——都可以通过代谢调节来实现。在本文中,我们回顾了证明代谢途径在支持肿瘤发展早期阶段的过程中起着关键作用的证据。我们讨论了细胞内因素,如起源细胞或转化致癌基因,以及细胞外因素,如局部营养物质的可用性,如何促进或抑制肿瘤起始。更深入地了解代谢途径如何控制肿瘤起始将提高我们设计代谢干预措施来限制肿瘤发生率的能力。